COMBIPHAR
Erik Darmawan has a strong background in various industries, with their most recent role being the Head of CRM consumers and costumers at PT. Combiphar. In this role, they transformed the company's interaction with consumers and built consumer engagement platforms and an e-commerce platform. Prior to this, they worked as a Transition team senior member at PT. XL Axiata Tbk. Erik also served as the Head of Marketing Segment at PT. AXIS Telekom Indonesia and held positions at PT. Huawei Tech. Investment and PT. Datamation Purwana Utama, where they worked as a Network Security Product Manager, Business Representative, and Network Engineer.
Erik Darmawan pursued their undergraduate studies at Atma Jaya Catholic University of Indonesia from 1995 to 2000, majoring in Electrical Engineering. Following this, they enrolled in Universitas Gadjah Mada (UGM) where they obtained a Master's degree in Management from 2003 to 2006.
This person is not in any teams
This person is not in any offices
COMBIPHAR
1 followers
Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement. Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia. Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology. Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.